Sena, Anthony G
Erasmus MC
6 papers on CoChatORCID 0000-0001-8630-5347
Most cited papers
- Verified
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology
Rheumatoid Arthritis Research and TherapiesPharmacovigilance and Adverse Drug Reactions
Cited by 258
- Verified
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., et al. (2021) · BMJ
Pharmacovigilance and Adverse Drug ReactionsSARS-CoV-2 and COVID-19 Research
Cited by 219
- Verified
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
Cai, C. X., Hribar, M., Baxter, S., Goetz, K., Swaminathan, S. S., Flowers, A., Brown, E. N., Toy, B., Xu, B., Chen, J., et al. (2025) · JAMA Ophthalmology
Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity
Cited by 129
- Verified
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
Prats-Uribe, A., Sena, A. G., Lai, L. Y. H., Ahmed, W.-U.-R., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Carter, W., Casajust, P., et al. (2021) · BMJ
COVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts
Cited by 68
- Verified
Health-Analytics Data to Evidence Suite (HADES): open-source software for observational research.
Schuemie, M., Reps, J., Black, A., Defalco, F., Evans, L., Fridgeirsson, E., Gilbert, J. P., Knoll, C., Lavallee, M., Rao, G. A., et al. (2024) · Studies in Health Technology and Informatics
Machine Learning in HealthcareMedical Coding and Health Information
Cited by 28
- Verified
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab
Cai, C. X., Nishimura, A., Bowring, M. G., Westlund, E., Tran, D., Ng, J. H., Nagy, P., Cook, M., McLeggon, J.-A., DuVall, S. L., et al. (2024) · Ophthalmology Retina
Retinal Diseases and TreatmentsDrug-Induced Ocular Toxicity
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free